Among individual players, Aurobindo Pharma, Dr Reddys Labs, and Zydus Lifesciences sourced 48 per cent, 47 per cent, and 46 per cent of their total revenues from the US generics segment, respectively
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
